Literature DB >> 24686896

Persistent pain facilitates response to morphine reward by downregulation of central amygdala GABAergic function.

Zhi Zhang1, Wenjuan Tao2, Yuan-Yuan Hou3, Wei Wang3, Yun-Gang Lu4, Zhizhong Z Pan3.   

Abstract

Opioid-based analgesics are widely used for treating chronic pain, but opioids are highly addictive when repeatedly used because of their strong rewarding effects. In recent years, abuse of prescription opioids has dramatically increased, including incidences of misuse of opioid drugs prescribed for pain control. Despite this issue in current clinical pain management, it remains unknown how pain influences the abuse liability of prescription opioids. Pain as aversive experience may affect opioid reward of positive emotion through common brain sites involved in emotion processing. In this study, on a rat model of chronic pain, we determined how persistent pain altered behavioral responses to morphine reward measured by the paradigm of unbiased conditioned place preference (CPP), focusing on GABAergic synaptic activity in neurons of the central nucleus of the amygdala (CeA), an important brain region for emotional processing of both pain and reward. We found that pain reduced the minimum number of morphine-conditioning sessions required for inducing CPP behavior. Both pain and morphine conditioning that elicited CPP inhibited GABA synaptic transmission in CeA neurons. Pharmacological activation of CeA GABAA receptors reduced the pain and inhibited CPP induced both by an effective dose of morphine and by a sub-threshold dose of morphine under pain condition. Furthermore, inhibition of CeA GABAA receptors mimicked the pain effect, rendering the sub-threshold dose of morphine effective in CPP induction. These findings suggest that pain facilitates behavioral responses to morphine reward by predisposing the inhibitory GABA function in the CeA circuitry involved in the behavior of opioid reward.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24686896      PMCID: PMC4104345          DOI: 10.1038/npp.2014.77

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  62 in total

1.  Projections from the nociceptive area of the central nucleus of the amygdala to the forebrain: a PHA-L study in the rat.

Authors:  L Bourgeais; C Gauriau; J F Bernard
Journal:  Eur J Neurosci       Date:  2001-07       Impact factor: 3.386

2.  Alternative diagnostic criteria for major depressive disorder in patients with chronic pain.

Authors:  Keith G Wilson; Samuel F Mikail; Joyce L D'Eon; Joanne E Minns
Journal:  Pain       Date:  2001-04       Impact factor: 6.961

3.  Upregulation of nerve growth factor in central amygdala increases sensitivity to opioid reward.

Authors:  Bihua Bie; Yan Wang; You-Qing Cai; Zhi Zhang; Yuan-Yuan Hou; Zhizhong Z Pan
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

Review 4.  Chronic pain and addiction: challenging co-occurring disorders.

Authors:  Mel Pohl; Logan Smith
Journal:  J Psychoactive Drugs       Date:  2012 Apr-Jun

5.  Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats.

Authors:  F C Colpaert; J P Tarayre; M Alliaga; L A Bruins Slot; N Attal; W Koek
Journal:  Pain       Date:  2001-03       Impact factor: 6.961

Review 6.  Pain modulation: expectation, opioid analgesia and virtual pain.

Authors:  H L Fields
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

7.  The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release.

Authors:  N Tian; C Petersen; S Kash; S Baekkeskov; D Copenhagen; R Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 8.  Stress, corticotropin-releasing factor, and drug addiction.

Authors:  G F Koob
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

9.  Hippocampal hyperexcitability underlies enhanced fear memories in TgNTRK3, a panic disorder mouse model.

Authors:  Mónica Santos; Davide D'Amico; Ornella Spadoni; Alejandro Amador-Arjona; Oliver Stork; Mara Dierssen
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

Review 10.  The contextual brain: implications for fear conditioning, extinction and psychopathology.

Authors:  Stephen Maren; K Luan Phan; Israel Liberzon
Journal:  Nat Rev Neurosci       Date:  2013-05-02       Impact factor: 34.870

View more
  17 in total

Review 1.  Corticolimbic circuitry in the modulation of chronic pain and substance abuse.

Authors:  Anna M W Taylor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-05-10       Impact factor: 5.067

2.  Transmission pathways and mediators as the basis for clinical pharmacology of pain.

Authors:  Daniel R Kirkpatrick; Dan M McEntire; Tyler A Smith; Nicholas P Dueck; Mitchell J Kerfeld; Zakary J Hambsch; Taylor J Nelson; Mark D Reisbig; Devendra K Agrawal
Journal:  Expert Rev Clin Pharmacol       Date:  2016-07-04       Impact factor: 5.045

3.  Methylphenidate and Morphine Combination Therapy in a Rat Model of Chronic Pain.

Authors:  Zerong You; Weihua Ding; Jason T Doheny; Shiqian Shen; Jinsheng Yang; Liuyue Yang; Lucy Chen; Shengmei Zhu; Jianren Mao
Journal:  Anesth Analg       Date:  2020-02       Impact factor: 5.108

4.  Incisional Injury Modulates Morphine Reward and Morphine-Primed Reinstatement: A Role of Kappa Opioid Receptor Activation.

Authors:  Chinwe A Nwaneshiudu; Xiao-You Shi; J David Clark
Journal:  Anesth Analg       Date:  2020-01       Impact factor: 5.108

5.  Sensitized brain response to acute pain in patients using prescription opiates for chronic pain: A pilot study.

Authors:  Logan T Dowdle; Jeffrey J Borckardt; Sudie E Back; Katherine Morgan; David Adams; Alok Madan; Wendy Balliet; Colleen A Hanlon
Journal:  Drug Alcohol Depend       Date:  2019-04-23       Impact factor: 4.492

6.  Persistent pain maintains morphine-seeking behavior after morphine withdrawal through reduced MeCP2 repression of GluA1 in rat central amygdala.

Authors:  Yuan-Yuan Hou; You-Qing Cai; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

7.  Neuroinflammation-a co-occurring phenomenon linking chronic pain and opioid dependence.

Authors:  Catherine M Cahill; Anna Mw Taylor
Journal:  Curr Opin Behav Sci       Date:  2017-01-06

8.  GluA1 in Central Amygdala Promotes Opioid Use and Reverses Inhibitory Effect of Pain.

Authors:  Yuan-Yuan Hou; You-Qing Cai; Zhizhong Z Pan
Journal:  Neuroscience       Date:  2019-12-19       Impact factor: 3.590

Review 9.  Factors mediating pain-related risk for opioid use disorder.

Authors:  Arbi Nazarian; S Stevens Negus; Thomas J Martin
Journal:  Neuropharmacology       Date:  2021-01-30       Impact factor: 5.250

10.  Neurobiological aspects of pain in the context of alcohol use disorder.

Authors:  Jessica A Cucinello-Ragland; Scott Edwards
Journal:  Int Rev Neurobiol       Date:  2020-10-06       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.